Chronic obstructive pulmonary disease (COPD) is an inflammatory disease that causes obstructed airflow from the lungs, and it is expected to be the third leading cause of death globally by 2030. At present, only symptomatic therapies for COPD are available.
All news from R&D
Enrollment has begun in an early-stage clinical trial testing the safety of two human monoclonal antibodies (mAbs) designed to treat people infected with Middle East respiratory syndrome coronavirus (MERS-CoV).
For patients with sepsis, a serious infection causing widespread inflammation, immediate treatment is essential to improve the chances of survival. An updated "Hour-1 Bundle" of the international, evidence-based guidelines for treatment of sepsis is introduced in the issue of Critical Care Medicine. The official journal of the Society of Critical Care Medicine (SCCM), Critical Care Medicine is published in the Lippincott portfolio by Wolters Kluwer.
KARL STORZ Endoscopy-America, Inc., announces the commercial launch of the PDD Blue Light Flexible Video Cystoscopy System for enhanced detection of non-muscle invasive bladder cancer (NMIBC). This announcement follows the approval of a supplemental new drug application and a Premarket Approval supplement from the USFDA extending the indication for Blue Light Cystoscopy with Cysview®(BLCC) to include use of the new KARL STORZ PDD Blue Light Flexible Video Cystoscope.
Hospice at home (HAH) services aim to enable patients to be cared for and die in their place of choice, if that is at home, and to achieve a ‘good death’. There is a considerable range of HAH services operating in England. The published evidence focuses on evaluations of individual services which vary considerably, and there is a lack of consistency in terms of the outcome measures reported.
Vaccination against the human papillomavirus (HPV) is highly protective against precancerous cervical lesions in adolescents and young women compared with placebo, especially those who are negative for HPV at the time of vaccination, a systematic Cochrane review concludes.
Propelled by improvements in health and education, reduced vulnerability, and economic growth, Bangladesh is expected to leave the LDC category by 2024. The country has witnessed significant struggles to improve the well-being of its people. It has successfully continued to maintain a six-percent growth over the last six years for which the efforts of its government and especially relentless hard work by the working-class people are to be credited.
Importantly, the country has done remarkably well in reducing extreme poverty from 34% down to 13% in just 16 years (World Bank, 2017). However, the question is what else it needs to do to maintain its progression.
The risk for asthma is elevated in women taking oral contraceptives, new research shows. "What can we do with this information? That is the tricky part," said Joe Zein, MD, from the Cleveland Clinic, who presented the finding at the American Thoracic Society 2018 International Conference in San Diego. "We need more data."
Mosquitoes may increase the severity of the diseases they transmit, and researchers think that mosquito saliva plays an active role in this process. Researchers have taken a closer look at the effect of mosquito saliva alone and found that it can trigger an unexpected variety of immune responses in an animal model of the human immune system.
These results offer an opportunity to develop effective strategies to prevent mosquito-based transmission of disease. The study appears in the journal PLOS Neglected Tropical Diseases.
On Earth, tissue weight generates compressive forces that press on body structures and act on the walls of vessels throughout the body. In microgravity tissues no longer have any weight and tissue compressive forces are lost, suggesting individuals who weigh more may show greater effects from microgravity exposure. One unique effect of long-duration microgravity exposure is the spaceflight-associated neuro-ocular syndrome (SANS) which can present with globe flattening, choroidal folds, optic disc edema, and a hyperopic visual shift.
The aim of this consultation was to address implementation challenges in Non-Communicable Diseases (NCDs) and prioritize actions for effective implementation.
After conducting 2 State level consultations with National Health Mission in 2017, Project HOPE and Eli Lilly and Company (India Pvt. Ltd.) successfully conducted the 3rd and final consultation at the national level. The aim of this consultation was to address implementation challenges in Non-Communicable Diseases(NCDs) and prioritize actions for effective implementation.